Table 1. Demographic and clinical data of our study sample.
Non-IFIS group (n=1211) | IFIS group (n=63) | P-value | |
---|---|---|---|
Mean±SD | |||
Age (years) | 71.8±9.2 | 73.3±6.1 | 0.219a |
Axial length (mm) | 23.7±1.4 | 22.3±1.8 | 0.027a |
N (%) | |||
Male sex | 642 (53.0) | 47 (74.6) | <0.001b |
Hypertension | 812 (67.1) | 51 (81.0) | 0.031b |
Diabetes mellitus | 184 (15.2) | 11 (17.5) | 0.592b |
Pseudoexfoliation | 233 (19.2) | 13 (20.6) | 0.745c |
Glaucoma | 127 (10.5) | 8 (12.7) | 0.531c |
Retinal disorders | 153 (12.6) | 6 (9.5) | 0.561c |
Tamsulosin use | 117 (9.7) | 18 (28.6) | <0.001c |
Alfuzosin use | 109 (9.0) | 12 (19.0) | 0.014c |
Terazosin use | 49 (4.0) | 6 (9.5) | 0.050c |
Benzodiazepine use | 103 (8.5) | 11 (17.5) | 0.023c |
Finasteride use | 59 (4.9) | 8 (12.7) | 0.015c |
Rivastigmine use | 3 (0.2) | 2 (3.2) | 0.022c |
Quetiapine use | 8 (0.7) | 3 (4.8) | 0.014c |
Warfarin/aspirin use | 265 (21.9) | 19 (30.2) | 0.123c |
Abbreviations: IFIS, intraoperative floppy iris syndrome; SD, standard deviation.
P-value derived from Mann–Whitney–Wilcoxon test for independent samples.
P-value derived from χ2-test.
P-value derived from Fisher's exact test. Bold cells denote statistical significance.